American Public Education - Q2 2024

Transcript

Operator (participant)

Hello, and welcome to the American Public Education, Inc.'s second quarter 2024 earnings call. All lines have been placed on mute to prevent any background noise. After the speaker's remarks, there will be a question and answer session, and if you would like to ask a question at that time, please press star one on your telephone keypad. I would now like to turn the conference over to Brian Prenoveau, Investor Relations. You may begin.

Brian Prenoveau (Head of Investor Relations)

Thank you, Sarah, and good afternoon, everyone. Welcome to American Public Education's conference call to discuss second quarter 2024 results. Joining me on the call today are Angela Selden, President and Chief Executive Officer; Rick Sunderland, Executive Vice President and Chief Financial Officer; Steve Somers, Senior Vice President and Chief Strategy and Corporate Development Officer. Materials for the call today are available in the Quarterly Reports section of APEI's website.

Statements made during this conference call and any accompanying presentation regarding APEI and its subsidiaries that are not historical facts may be considered forward-looking statements based on current expectations, assumptions, estimates, and projections. Forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements.

Forward-looking statements may sometimes be identified by words like anticipate, believe, seek, could, estimate, expect, can, may, plan, potentially, project, should, will, would, and similar or opposite words. Forward-looking statements include, without limitation, statements regarding expectations for registrations and enrollments, revenue, earnings, and adjusted EBITDA and other earnings guidance, repositioning Rasmussen University for growth, changing market demands, and our ability to satisfy such demands and other company initiatives, including with respect to future competition and demand, cost savings efforts. This presentation contains references to non-GAAP financial information.

A reconciliation between the non-GAAP financial measures we use and the most directly comparable GAAP measures is located in the appendix to today's presentation and in the earnings release. Management believes that the presentation of non-GAAP financial information provides useful supplemental information to investors regarding its results of operations and should only be considered in addition to and not as a substitute for or superior to any measure of financial performance prepared in accordance with GAAP. Now, I'd like to turn the call over to APEI's CEO, Angela Selden. Angela, Angie, please go ahead.

Angela Selden (President and CEO)

Thank you, Brian. Good afternoon, and thank you for joining American Public Education's second quarter 2024 earnings call. For those of you new to APEI, our four postsecondary institutions are among the largest in the country in educating adult learners, with an emphasis on educating those in service to others, namely new nurses, active duty military, veterans, first responders, and the federal workforce. On an annual basis, APEI provides online and campus-based postsecondary education and career learning to approximately 125,000 adult learners worldwide.

Our mission is to power, purpose, potential, and prosperity to those in service to others. On today's call, we will cover in more detail the following good news highlights. First, in Q2 2024, this marked the seventh consecutive quarter where APEI's adjusted EBITDA has met or exceeded guidance. Overall, APEI revenue grew 3.9% year-over-year to $152.9 million. We saw significant improvement in APEI's adjusted EBITDA, which grew 24% to $10.9 million, primarily driven by year-over-year operating expense at both Rasmussen and APEI Corporate. Adjusted EBITDA margin expanded by 118 basis points to 7.2% when compared to 2Q 2023.

Next, I'm pleased to report that Rasmussen has achieved its first year-over-year positive revenue and enrollment quarter since our acquisition in 2021, and as we had signaled earlier this year. Finally, we are reiterating our full year guidance of revenue between $620 million and $630 million in revenue and adjusted EBITDA between $60 million and $70 million. Now I'd like to provide more detail about the results and trajectory of our education units, starting first with Rasmussen. I'm very pleased with the progress we have made to stabilize and put Rasmussen back on a trajectory for revenue and enrollment growth and positive EBITDA.

Second quarter enrollments, which we shared in our last earnings call, were 13,600, down just 2%. More importantly, third quarter enrollments, which we are sharing for the first time today, grew slightly on a year-over-year basis to 13,500 students, powered by double-digit growth in our nursing and health sciences online programs and is the positive turn in the business toward which we've been working.. This is particularly noteworthy as Rasmussen decided to suspend new enrollment in its two Wisconsin campuses, which operate in small markets, while it continues to optimize the campus footprint to improve profitability and to strengthen margins.

While we don't typically report starts, I think it's important to note that start growth was nearly 10% in the quarter and reflected positive year-over-year start growth in both the Rasmussen Online and Rasmussen campus portions of the business. The continued momentum in enrollments also corresponds with growth in revenue, where Rasmussen revenue was up 2%, which is also the first time since APEI's acquisition and is indicative of the path to continued growth and profitability. EBITDA for the Rasmussen segment was negative in the quarter, but the loss narrowed to -$4.7 million from -$7.1 million in the prior year period.

In conjunction with the expected growth in enrollments in the second half, we continue to expect Rasmussen to move into positive EBITDA territory in the fourth quarter of 2024, which sets us up for a much stronger profit picture in 2025. In terms of student outcomes, we again produced strong NCLEX pass rates in the second quarter, where 22 of 25 programs are meeting the required thresholds year to date. Now, I'd like to turn our attention to APEI's online university, serving military and veterans, APUS. In 2Q 2024, overall net course registrations increased 1.7% year-over-year, reflecting the strong retention of returning students. Revenue at APUS was higher due to the overall growth in registrations, as well as higher average revenue per registration from last year's modest tuition and fee increases.

As APUS has invested in 2024 to strengthen its online curriculum, implement a faculty pay increase for part-time faculty, invest in IT infrastructure optimization, and better align its marketing spend, 2Q EBITDA margin was slightly lower year-over-year. Looking ahead to the third quarter, we would expect EBITDA margins at APUS to be similar given those same factors. At Hondros, as previously reported, 2Q 2024 enrollment remained strong. We also saw growth continue in 3Q 2024, with enrollment increasing more than 10% year-over-year to 3,100 students, even against a strong 17% comp a year ago. Demand remains strong for both the PN and ADN nursing program, with the new Detroit campus performing very well.

Legacy campus also contributed to growth, including Indianapolis, where we still operate with enrollment caps as a new program, despite exceptional NCLEX pass rates. Starts at Hondros remain robust, and we continue to be pleased with the growth we are seeing. In 3Q 2024, Hondros has relocated one of its Ohio campuses and has experienced some unexpected infrastructure setbacks in that location, which we expect will result in some temporary but limited impact to enrollment at that one location. Overall, with the stabilization of enrollments and continued improvement in Adjusted EBITDA at Rasmussen, at APEI, we are now delivering positive growth in revenue, Adjusted EBITDA, and margins on a consolidated basis.

Before turning the call over to Rick Sunderland, APEI CFO, I'd like to frame where we are as an enterprise and provide some specificity as to where we're headed. With the stabilization of Rasmussen well underway, including line of sight to continued enrollment and revenue growth from that unit, we see margins at Rasmussen shifting from negative to positive in the fourth quarter, setting the stage for 2025 and beyond. Rasmussen also expects to expand its campus footprint for the first time in over five years once the Department of Education growth restrictions are lifted, which will allow us to expand our impact in addressing the large demand for nursing and other clinical roles in our overstretched healthcare system.

We fundamentally believe in our vision that education can transform lives, advance careers, and improve communities. Our four education units were built for service-minded students, offering accessible and affordable higher education and training across a diverse range of subjects. At APEI, we have carved out distinctive market positions. American Military University, or AMU, is the number one provider of higher education to the U.S. military and has been named the top choice nationwide for veterans using their GI Bill benefit. Hondros College of Nursing focuses on educating pre-licensure nursing students at eight campuses and is the number one provider of pre-licensure PN education in the state of Ohio.

Both Hondros and Rasmussen continue to tackle the chronic nursing shortage by graduating thousands of new nurses each year, where the demand for nurses is expected to grow significantly to 3.3 million in 2031. An increase of 195,000, and an additional 203,000 job openings each year when retirement and workforce exits are factored in. Overall, higher education remains a critical accelerator for anyone seeking employment in the U.S., with an increasing amount of working adult students driving the higher education market, which is expected to reach approximately $173 billion by 2030. We are proud that APEI is affordable, learn to earn focus, enables students to experience a strong, lifelong return on their educational investment. With that, let me turn the call over to APEI CFO, Rick Sunderland.

Rick Sunderland (EVP and CFO)

Thank you, Angie. Total revenue in the second quarter was $152.9 million, up $5.7 million, or 3.9% from the prior period. Second quarter revenue growth was driven by increased revenue at APUS, Hondros, and Rasmussen, partially offset by a revenue decline at Graduate School, which was approximately $1 million less than our guidance. Total costs and expenses in the second quarter decreased $61.8 million or 29.1% compared to the second quarter of 2023, which included a non-cash impairment charge of $64 million to reduce the carrying value of our new segment, goodwill and intangible assets, and the corresponding tax impact.

Costs and expenses for the second quarter as compared to the prior period, excluding loss on leases, severance costs, and information technology transition services costs in 2024, and goodwill and intangible asset impairment charges in 2023 increased $0.7 million to primarily to increases in other technology and marketing expenses. Second quarter diluted loss per common share improved significantly and was a loss of $0.06, compared to an adjusted net loss of $0.25 in the prior year quarter, which excludes the $64 million goodwill and intangible asset impairment. For the quarter, Adjusted EBITDA increased 24% to $10.9 million, compared to $8.8 million in the prior period. The second quarter results were at the high end of guidance and represented an Adjusted EBITDA margin of 7.2%, as compared to 6% in the prior year quarter.

At APUS, second quarter revenue increased 4.7% as compared to the prior year to $77 million, due to a 1.7% increase in net course registrations, driven by an increase in registrations by military-affiliated students utilizing VA benefits, and tuition and fee increases in the second and third quarters of 2023. In total, EBITDA margin at APUS was 25%, compared to 28% in the prior year. The change in margin was primarily due to increased information technology, employee compensation, and advertising costs. At Rasmussen, second quarter revenue was $53 million, an increase of 2% compared to the prior year, due to an increase in tuition in the first quarter of 2024, partially offset by a 2.2% decrease in total student enrollment.

The decline in total student enrollment was driven by an 8.8% decrease in on-ground enrollment, partially offset by a 4.2% increase in online enrollment, which has a lower revenue per student as compared to the prior year period. As Angie mentioned, the year-over-year enrollment declines have narrowed in each of the past 5 quarters, and third quarter total enrollment is up slightly. In the second quarter, Rasmussen's EBITDA improved to a loss of $4.7 million, compared to an EBITDA loss in the prior period of $7.1 million, representing an approximate 33% year-over-year improvement after adjusting for last year's goodwill impairment, this year's loss on leases. At Hondros, second quarter revenue was up 15% to $16.4 million as compared to the prior year period, due to continued enrollment growth and the 2023 tuition increase.

For the quarter, Hondros' total enrollment grew 9.4% to approximately 3,300 students, the third consecutive record-setting quarter for enrollment. For the quarter, Hondros' EBITDA loss was a loss of $0.4 million, compared to positive EBITDA of $0.1 million in the prior year period. Revenue at Graduate School, included in corporate and other, was $6.5 million, compared to $7.5 million in the prior year period. For the quarter, Graduate School's EBITDA loss was $0.7 million, compared to positive EBITDA of $0.8 million in the prior year period. At June thirtieth, 2024, total cash, cash equivalents, and restricted cash was $156.2 million, an increase of $11.8 million from year-end 2023.

For the six months ended June 30, 2024, cash flow from operations increased 16% to $33.2 million compared to the prior year. CapEx for the first six months was $11.4 million, and free cash flow, defined as adjusted EBITDA less CapEx, was $16.6 million, compared to $9.2 million in the prior year a year ago. Principal on APEI's term loan at June 30 was $96 million. With unrestricted cash of $130 million, APEI continues to be net cash positive. Additionally, there are no borrowings under APEI's $20 million revolving credit facility, which remains fully available. Turning now to the third quarter 2024 outlook. APUS total net course registrations are expected to be flat to slightly down compared to the prior, between 90,500 to 92,300 registrations.

We believe the softness in third quarter APUS registrations is largely attributable to changes in marketing spend in late 2023, which typically has a 2- to 3-quarter lag in registration numbers. Appropriate adjustments are being made to marketing spend to correct this decline. At Rasmussen and Hondros, third quarter student enrollments are actual because of the quarterly starts at these schools. At Rasmussen, third quarter on-ground enrollment decreased -5% to approximately 6,030 students, while total online student enrollment increased 4.7% year-over-year to approximately 7,440 students, for an aggregate enrollment of approximately 13,500 students. This represents a slight increase when compared to the third quarter of 2023, and it's the first quarter of positive year-over-year enrollment growth since the acquisition.

At Hondros, third quarter total student enrollment increased 10% year-over-year to approximately 3,100 students. In the third quarter of 2024, consolidated revenue is expected to be between $152 million and $155 million. The company expects net income to common shareholders to be between a loss of $1.2 million and income of $1 million, or between a loss of $0.06 and income of $0.05 per diluted share. Adjusted EBITDA is expected to be between $9 million and $12 million in the third quarter of 2024. Our full year guidance is unchanged, with anticipated consolidated full year 2024 revenue in a range of $620 million-$630 million.

We expect our adjusted EBITDA to be between $60 million-$70 million full year. The second and third quarters tend to be seasonally low quarters, with a notable increase in Adjusted EBITDA in the fourth quarter, especially as Rasmussen continues ramping in the fourth quarter. I will now pass it back to Angie to offer some closing remarks, after which we will begin our question and answer session. Angie?

Angela Selden (President and CEO)

Thank you, Rick. During this quarter, we continued to execute our strategic initiatives to grow enrollment at APUS and stabilize and increase profitability at our other units. We're further encouraged by the performance at Rasmussen, as enrollment numbers have stabilized and had the first year-over-year improvement since our acquisition. Market fundamentals continue to support our business strategy, with increasing growth in higher education and online education markets, and significant government education benefits for military and veterans.

With our number one market position in active duty military and veterans, and focus on high-demand sectors like nursing, we are well positioned to capitalize on this growth. As we move ahead in 2024 and continue to execute on our key milestones, I believe that we have built a foundation of a business that can continue to deliver to its students value, to its stakeholders value, and to their communities value for years to come. And with that, I would now like to hand the call back to the operator to begin our question and answer session. Operator?

Operator (participant)

Thank you, Angie. If you would like to ask a question, please press star one on your telephone keypad. To withdraw your question, simply press star one again. Please ensure that your line is not on mute when called upon. Your first question comes from the line of Raj Sharma with B. Riley. Your line is open.

Raj Sharma (Stock Analyst)

Yeah, thank you for taking my questions. I wanted to understand a little bit, maybe get some color on Rasmussen. I see the improvement in the enrollment is now almost flat and projected to be almost flat next quarter. Where, you know, can this business—what can this business do and is capable of, specifically, you know, not as much in the year-on-year growth from here, but really on the EBITDA margins?

You know, you're getting, you had -9 this quarter in the EBITDA margins. You know, what could these get to in the second half? And more sort of longer term, fiscal 2025, 2026, relative to where they were, you know, when you purchased Rasmussen or what the original capability of the operation is? Thank you.

Angela Selden (President and CEO)

Raj, thank you very much for that question. That's a lengthy question with many component parts to it. So let me start by saying, as we signaled, we believe 2H 2024 is where Rasmussen will turn to positive Adjusted EBITDA, and we see line of sight to that. We're excited about that. Several of the things that we believe will have a positive effect on 2025 include the completion of our exiting of the third-party IT agreement with Collegis, and we expect to see meaningful savings on a full year run rate basis in 2025 as a result.

Certainly, as we turn the corner on the enrollment, to positive momentum, in the fourth quarter and in 2025 and beyond, we believe that that will have a meaningful, improvement in our Adjusted EBITDA, for each, each new dollar of revenue. We're now, more than covering the fixed costs, and that has a very significant effect on our Adjusted EBITDA in 2025 and beyond. We're not presently giving guidance on 2025, but I'll turn it over to Steve with, any other comments he'd like to share.

Steve Somers (SVP and Chief Strategy and Corporate Development Officer)

Yeah, Raj, I'll just add some context around there. Right. In the industry, in general, nursing schools and schools similar to Rasmussen operate in the, you know, 10%-15% and 15+% range. We're obviously working to improve that quarter to quarter. Angie signaled that we're gonna be profitable in terms of EBITDA in the fourth quarter.

So I think it's reasonable to think that, you know, over time, we can get to, you know, 5%-10% margins over the next 1-2 years. As you think about us inside the industry, that would be very consistent. And, you know, I think as you look forward to the third quarter, I think you asked about the second half as well, the third quarter, and then the fourth quarter, right?

We'll still be negative in the third quarter, but on a two-year basis, we would expect it to be positive overall for the second half and the fourth quarter itself. So hopefully that gives you a little bit of context around. You know, and I think the trend that has been in place for the last 12+ months is sort of trending in that general zone.

Raj Sharma (Stock Analyst)

Got it. And then could you talk a little bit about the APUS enrollment trends? And is this sort of flat to down a little expected? Is that seasonal, and where do you see overall those trends in enrollment?

Angela Selden (President and CEO)

I'll start, Raj, and then I'll have Rick provide more detail necessary. In Rick's remarks, he did discuss the decision in the fourth quarter of 2023 to dial back investments in marketing in certain segments of APUS. And there's a two-quarter lag that we see in terms of those investments turning into enrollment. So as we approach Q3, we are seeing the effect of that reduction in marketing spend, which has since been course-corrected, and we expect in the future quarters for that enrollment momentum to return. So Rick, I'm gonna turn it over to you for more detail.

Rick Sunderland (EVP and CFO)

Yeah, that's exactly right, Raj. And there is that lag, so I would suggest that, if things function as we expect, and we expect they will, the course correction we're making now or have been making recently will play out in the numbers over the two- or three-quarter lag. That's just the way the business functions. We remain strong.

In my comments, I talked about the strength of the military affiliate, and we remain strong in the veterans community. And quite frankly, our market share in active duty military is the highest it's ever been. And so we have continued strength there. The marketing will resolve over one to two quarters, maybe three.

Angela Selden (President and CEO)

Yeah. I think what I'll also say is that the, you know, the margin optimization efforts that were underway last year help us now understand the sensitivity around marketing spend. And so now that we understand that, we can be a lot more thoughtful in how we invest our marketing against certain channels and segments going forward.

And so we've tested that, and we now know where those boundaries are. And, you know, we also are seeing, in particular, a growing strength in the veterans market. It's something that we've been leaning into and wanting to see momentum build, and so we're quite pleased with the results we're seeing with veterans.

Raj Sharma (Stock Analyst)

Great. Thank you for answering my questions. That was very helpful. I'll take it offline. Thank you.

Angela Selden (President and CEO)

Okay. Thanks, Raj.

Operator (participant)

Once again, if you have a question, it is star one. Your next question comes from the line of Steven Sheldon with William Blair. Your line is open.

Matt Filek (Associate Analyst)

Hey, team, you have Matt Filek on for Steven. Thank you for taking my questions. Wanted to start with one on the full year guidance. Wondering if you could talk about some of the factors that would need to play out to push you toward the upper end of the guidance range, particularly for the revenue guide, which seems to assume a decent quarter-over-quarter step up in the fourth quarter based on the 3Q guide. I know there's some seasonality at play there, but any additional color would be helpful.

Angela Selden (President and CEO)

Yeah, I'll turn it over to Rick.

Rick Sunderland (EVP and CFO)

This is Rick. I'll start, and then Angie can fill in.

Angela Selden (President and CEO)

You bet.

Rick Sunderland (EVP and CFO)

Well, if you wanna push up through that range, things that would have to go favorably would be a quicker, call it, uptake on the marketing spend at APUS, right? We talked about what has been observed as a typical lag between altering a spend, be it total dollars or allocation among segments, and then the resulting improvement in registrations. If that accelerates, then, of course, that would push revenue up higher in the range.

We're seeing, you know, strength at Rasmussen, right? We've got the turn, a slight improvement year-over-year, and that momentum will continue. And I think Angie commented on the strength of the start numbers, right, which is a leading indicator as it relates to total enrollment. And that strength could accelerate or build on itself to push us up.

Then you drop down to Hondros. They've got a new program that they're introducing. As a new program, we don't have observable experience in medical assisting as to how that enrollment pattern will ultimately play out. That could go up or go down, right? It's just a, it's a new program. And then graduate school, we've got Steve Summers, who's in the room here, who's back.

And while it's a smaller piece of the overall enterprise, it sort of had an impact on the Q2 reported results. And then, of course, the opposite could be true. An uptake of 1 million or 2 million there in the federal workforce would obviously be very helpful against the range. So I'll pause there and let Angie, Angie add to the comments.

Angela Selden (President and CEO)

I think that's a pretty good synopsis. You know, the last thing I would say is that we've passed along price increases at certain segments across APUS, Hondros, and Rasmussen, and assuming that those price increases continue to hold, without degradation in our student enrollments, that'll also play favorably in the overall overall revenue that we would expect for the full year.

Matt Filek (Associate Analyst)

Got it. That's a helpful color. Thank you, Angie and Rick. And then had another one on NCLEX scores. I imagine this is tougher to call, but do you have any rough estimate on when you might have all of your nursing programs with first-time NCLEX pass rates that exceed state nursing board standards? I know you continue to make good progress on that with the variety of initiatives you have underway, but any sense of timing on completely resolving those first-time NCLEX pass rate issues at the remaining campuses?

Angela Selden (President and CEO)

Sure. The one campus that we are paying attention to is in Illinois, where we have done significant amount of renewing of faculty that we're upgrading the curriculum. That campus was operating with an older version of the curriculum that was not aligned with the Next Gen NCLEX testing. And so we believe that the turn on NCLEX scores in Illinois will be slower than the two other remaining campuses.

So, but we are incredibly happy with the NCLEX results that we're posting now. All of our BSN programs, all of them, are above the state standards, all but one in our ADN program, which had been an area of challenge for us in the past, and two of our PN programs. And so we're just very, very pleased with the incredible turn that Rasmussen has demonstrated in terms of improving its NCLEX pass rate.

Steve Somers (SVP and Chief Strategy and Corporate Development Officer)

Matt, Steve, let me just say one more comment to that. If you, if you went back in terms of the number of programs that are passing today, year to date, 22 out of 25, that is, that is now higher than it was in the prior 2 years before we acquired the business. So we've obviously made a lot of improvement in the, in the near term, but now we're on a path to a better result on a longer-term longer trend basis as well.

Matt Filek (Associate Analyst)

Perfect. That's great color, and, yeah, great to see the continued progress there. Thank you.

Angela Selden (President and CEO)

Thank you.

Operator (participant)

Your next question comes from the line of Jasper Bibb with Truist Securities. Your line is open.

Jasper Bibb (VP and Senior Equity Analyst)

Hey, everyone. Apologies if, if anything has been answered already. I, I joined a little bit late from another call. Just wanted to ask about Rasmussen Nursing.

I, I guess, is there any update on the, the Florida RU campuses from last quarter? And I think there's also potentially a bill in Illinois to help you a bit with the, the campus you mentioned, on, on the last answer. Is there any change there?

Angela Selden (President and CEO)

Sure. So Jasper, I'm not exactly sure what specifically you mean relative to the Florida campuses, so I'll start with NCLEX results, where we have all program campus combinations meeting the state standard for the year-to-date measurement period. So we're very, very pleased with the incredible turnaround that we've had in NCLEX performance in Florida. Can you repeat the... If, if that doesn't answer your question, is there something more specific here you had in mind?

Jasper Bibb (VP and Senior Equity Analyst)

No, no, that's helpful. I think last quarter there was basically a technical thing where you had a really old cohort that triggered some of those campuses going on probation, and it sounded like everything was-

Angela Selden (President and CEO)

Yeah, that's right.

Jasper Bibb (VP and Senior Equity Analyst)

kind of moving in the right direction.

Angela Selden (President and CEO)

Yeah. We've been really happy with the results of pushing through and putting every single program campus combination in the green.

Jasper Bibb (VP and Senior Equity Analyst)

Okay, great. And yeah, the second part of the question was, I think there was a bill in Illinois that could give you some relief on a mentioned campus, a little bit longer turnaround time there. I think that bill might have afforded you, you know, a little more time to get that up to the relevant thresholds. Just kind of curious if there's any update there or that's still kind of in the works through their legislature.

Angela Selden (President and CEO)

Yes, that still remains in place, and so that relief affords us a two-year measurement period. We certainly aren't going to wait until the end. We're working very aggressively, and as I did mention, I think before you joined the call here, we've done two major things in Illinois to accelerate our performance in those campuses, including basically a replacement revitalization of several of the faculty there.

And importantly, we are modernizing the curriculum. Illinois, for a technical reason, a board of nursing reason, had required us to be operating with a curriculum that was older than the version of curriculum we had been offering in our other campuses. We were able to work with the board of nursing to allow them, or have them allow us to modernize that curriculum.

So now we're moving that curriculum to the next gen version, which is the version for the new exam, and we have a high degree of confidence that the new faculty, the dedicated attention from our nursing leadership, and the new curriculum will allow us to see significant improvements in our Illinois campuses in the future.

Jasper Bibb (VP and Senior Equity Analyst)

Well, that's very helpful. Thanks for taking the question.

Angela Selden (President and CEO)

Thank you.

Operator (participant)

This concludes our question and answer session. I'd now like to turn the call back over to Angie for closing remarks.

Angela Selden (President and CEO)

Thank you, operator. I'd like to thank each of you for joining our earnings conference call. We look forward to continuing to update you on our ongoing progress and growth as we continue our rapid pace of operational execution. If we were unable to answer any questions, please reach out to our IR firm, MZ Group, who would be more than happy to assist.

Operator (participant)

Ladies and gentlemen, this does conclude today's conference. Thank you for your participation. You may now disconnect your lines, and have a wonderful day.